Fri, October 15, 2021
Thu, October 14, 2021
Wed, October 13, 2021

Jeffrey Hung Downgraded (ACAD) to Hold and Held Target at $20 on, Oct 14th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-20-on-oct-14th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Jeffrey Hung of Morgan Stanley, Downgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Hold and Held Target at $20 on, Oct 14th, 2021.

Jeffrey has made no other calls on ACAD in the last 4 months.



There are 3 other peers that have a rating on ACAD. Out of the 3 peers that are also analyzing ACAD, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tazeen Ahmad of "B of A Securities" Maintained at Hold with Decreased Target to $25 on, Thursday, August 5th, 2021


These are the ratings of the 2 analyists that currently disagree with Jeffrey


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $26 on, Thursday, August 5th, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $28 on, Thursday, August 5th, 2021